Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterizing hyperexcitability in the C9orf72 ALS mouse
EF 2019-20
Résumé
"Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common motor neuron disease, which culminates in irreversible paralysis, respiratory dysfunction, and eventually death. There is significant heterogeneity in the site of initial symptom onset, genetic/environmental causes, and disease prognosis. Nonetheless, the disease course is extremely progressive, with approximately 50% of patients dying within the first 30 months of symptom onset. There are several proposed mechanisms underlying disease pathology, including a toxic mechanism that describes neurodegeneration caused by glutamate-mediated overstimulation of postsynaptic glutamate receptors, leading to excessive calcium ion (Ca2+) influx and eventual cell death. Current ALS therapies are limited due to the inability of several drugs to cross the blood-brain barrier, as well as significant heterogeneity in the genetic cause of the disease. Despite this genetic heterogeneity, previous research has identified a mutation in the C9orf72 gene as the most common genetic cause of ALS. However, little is known about the physiological mechanisms underlying C9orf72-mediated neurodegeneration. Therefore, using a C9orf72 mouse model, my aims are to 1) characterize electrical properties of neurons in the prefrontal cortex, motor cortex, and hippocampus - regions all impacted in C9orf72 models of ALS; 2) elucidate the mechanisms underlying aberrant electrical properties; and 3) determine whether treatment with Riluzole, a currently approved treatment for ALS, rescues aberrant electrical properties."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
428751
Name
de Saint-Rome Miranda
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing hyperexcitability in the C9orf72 ALS mouse
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Excitotxicity; Hyperexcitability; Neurodegeneration
Abstract
"Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common motor neuron disease, which culminates in irreversible paralysis, respiratory dysfunction, and eventually death. There is significant heterogeneity in the site of initial symptom onset, genetic/environmental causes, and disease prognosis. Nonetheless, the disease course is extremely progressive, with approximately 50% of patients dying within the first 30 months of symptom onset. There are several proposed mechanisms underlying disease pathology, including a toxic mechanism that describes neurodegeneration caused by glutamate-mediated overstimulation of postsynaptic glutamate receptors, leading to excessive calcium ion (Ca<sup>2+</sup>) influx and eventual cell death. Current ALS therapies are limited due to the inability of several drugs to cross the blood-brain barrier, as well as significant heterogeneity in the genetic cause of the disease. Despite this genetic heterogeneity, previous research has identified a mutation in the <em>C9orf72</em> gene as the most common genetic cause of ALS. However, little is known about the physiological mechanisms underlying <em>C9orf72</em>-mediated neurodegeneration. Therefore, using a <em>C9orf72</em> mouse model, my aims are to 1) characterize electrical properties of neurons in the prefrontal cortex, motor cortex, and hippocampus - regions all impacted in <em>C9orf72</em> models of ALS; 2) elucidate the mechanisms underlying aberrant electrical properties; and 3) determine whether treatment with Riluzole, a currently approved treatment for ALS, rescues aberrant electrical properties."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
de Saint-Rome, Miranda
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~